DK0555333T3 - Kunstige virushylstre - Google Patents

Kunstige virushylstre

Info

Publication number
DK0555333T3
DK0555333T3 DK91919952.1T DK91919952T DK0555333T3 DK 0555333 T3 DK0555333 T3 DK 0555333T3 DK 91919952 T DK91919952 T DK 91919952T DK 0555333 T3 DK0555333 T3 DK 0555333T3
Authority
DK
Denmark
Prior art keywords
viral envelopes
virus envelopes
artificial virus
production
envelopes
Prior art date
Application number
DK91919952.1T
Other languages
English (en)
Inventor
Hans Schreier
Ramesh Chander
Arlene A Stecenko
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of DK0555333T3 publication Critical patent/DK0555333T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91919952.1T 1990-10-19 1991-10-17 Kunstige virushylstre DK0555333T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60064190A 1990-10-19 1990-10-19

Publications (1)

Publication Number Publication Date
DK0555333T3 true DK0555333T3 (da) 1996-04-29

Family

ID=24404456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919952.1T DK0555333T3 (da) 1990-10-19 1991-10-17 Kunstige virushylstre

Country Status (8)

Country Link
EP (1) EP0555333B1 (da)
JP (1) JP3414395B2 (da)
AT (1) ATE132034T1 (da)
DE (1) DE69115924T2 (da)
DK (1) DK0555333T3 (da)
ES (1) ES2081502T3 (da)
GR (1) GR3018918T3 (da)
WO (1) WO1992006677A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101302536A (zh) 2000-02-02 2008-11-12 安增子摩祺株式会社 用于基因转移的病毒包膜载体
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
US20020155507A1 (en) 2000-10-06 2002-10-24 Bruchez Marcel P. Cells having a spectral signature, and methods of preparation and use thereof
EP1447080A1 (en) 2003-02-13 2004-08-18 Bestewil Holding B.V. Method for producing virosome-like particles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2650502C3 (de) * 1976-11-04 1980-01-17 Karl Dr.Med. 7302 Ostfildern Theurer Herstellung von Liposomen welche Arzneistoffe enthalten
EP0032578B1 (de) * 1980-01-16 1984-07-25 Hans Georg Prof. Dr. Weder Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
EP0047480B1 (en) * 1980-09-05 1986-02-05 Institut Armand Frappier Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
LU86736A1 (fr) * 1987-01-15 1988-08-23 Univ Bruxelles Liposomes sensibilises a des molecules antigeniques de parasites intracellulaires,procede pour les preparations et leurs applications comme moyens de diagnostic et comme agents d'immunisation
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
EP0306912A3 (en) * 1987-09-08 1989-07-05 Albany Medical College Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same.

Also Published As

Publication number Publication date
ES2081502T3 (es) 1996-03-16
DE69115924T2 (de) 1996-05-23
EP0555333B1 (en) 1995-12-27
JP3414395B2 (ja) 2003-06-09
ATE132034T1 (de) 1996-01-15
EP0555333A1 (en) 1993-08-18
GR3018918T3 (en) 1996-05-31
WO1992006677A1 (en) 1992-04-30
JPH06502412A (ja) 1994-03-17
DE69115924D1 (de) 1996-02-08

Similar Documents

Publication Publication Date Title
DE3789399T2 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
SE8101266L (sv) Arkmaterial for kardiovaskulera och andra protesimplantat
ATE135743T1 (de) Monoklonale menschliche antikörper gegen hiv-i
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
ATE20250T1 (de) Herstellung von hepatitis-a-virus mit hohem titer.
DE59103696D1 (de) Biomasse zur produktion von virus/virusantigen.
DK0555333T3 (da) Kunstige virushylstre
DE68924155T2 (de) Verfahren zur herstellung von natürlichem hiv-glykoprotein 160.
SE8100614L (sv) Humant relaxin och sett for framstellning derav
DE3587351T2 (de) Hämoglobin mit reduziertem virusrisiko und dessen herstellung.
ES2088458T3 (es) Fraccion antiviral de extracto acuoso de lentinus edodes.
DE69011856T2 (de) Herstellung von hefeextrakt.
DE69129863T2 (de) Herstellung von wellpappe
DE69109910D1 (de) Herstellung von Ethyl-tert.alkyläthern.
DK0498905T3 (da) Tilpassede epitoper af human immundeficiensvirus kappeglycoprotein gp120
DK447587D0 (da) Oxolabdaner, deres fremstilling og anvendelse
NL300073I1 (nl) Vaccin.
IT9019153A0 (it) Valvola cardiaca artificiale, con elevatissimo grado di sicurezza
DE59100308D1 (de) Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren.
DE69227368T2 (de) Herstellung von hepatitis a virus
IT1224877B (it) Insieme personalizzato,costituito da una busta racchiudente almeno due formati piegati, e procedimento per produrlo
ES2074085T3 (es) Precursor de la glicoproteina de envolvente del retrovirus hiv-2 y antigenos emparentados.
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids